SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-22-014838
Filing Date
2022-04-14
Accepted
2022-04-14 20:44:38
Documents
1
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 6095
  Complete submission text file 0000899243-22-014838.txt   7494
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ASPEN TECHNOLOGY, INC. 20 CROSBY DRIVE BEDFORD MA 01730
Business Address
Keresty Georgia (Reporting) CIK: 0001773532 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37766 | Film No.: 22828777